Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Thrombin generation assays warrant clinical caution pending validation; leaves open standardization and large-scale prospective studies.
Thrombin plays a central role in haemostasis through both procoagulant and anticoagulant functions. Although measurement of thrombin generation in the laboratory has been possible for many years, recent advances in understanding a wider scope of physiological roles of thrombin as well as improvements in technology have resulted in methods that are less technically demanding and more reproducible. Consequently, thrombin-generation assays continue to be evaluated as a potentially useful laboratory method for determining haemostatic abnormalities, including both bleeding and thrombotic conditions, and for monitoring anticoagulant therapy. Despite these advances limitations still remain, including lack of standardisation between methods and the reporting of few large, well-designed studies, although this is likely to change in the next few years.
No takes yet. Share an insight, caveat, or question.
MJ Adams (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: